Impact of CD44/326 peritoneal cells as response indicators in advanced gastric cancer patients receiving repeated intraperitoneal perfusion normothermic chemotherapy
The use of FC to identify PL CD44+/CD326+ cell levels may be an important innovative biomarker for determining the presence of NCs, directly affecting the success of RIPPENC for conversion surgery.
Authors
- Luiz Cláudio Santos Thuler (ORCID: https://orcid.org/0000-0003-2550-6537)
- Eliana Abdelhay (ORCID: https://orcid.org/0000-0001-5166-0832)
- Antônio Carlos Acetta
- Everton Cruz dos Santos (ORCID: https://orcid.org/0000-0002-3412-5325)
- Carlos Alexandre Vieira (ORCID: https://orcid.org/0000-0002-0083-2910)
- Cláudia Diniz (ORCID: https://orcid.org/0000-0003-3063-7136)
- Sérgio Bertolace
- Alexandre Palladino
- Rachel H. Rondinelli
- Odilon de Souza Filho
- Castro Guedes
Institutions
- Instituto Nacional de Câncer - INCA (BR)
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17588359251337480
- Citations
- 1
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro